FIRST QUARTER HIGHLIGHTS: Net sales: $788.3 million, up 23.8% y/y Gross profit: $128.3 million, up 27.6% y/y Net income: $21.8 million, up 114.0% y/y Diluted EPS: $0.83, up 113.6% y/y MERRIMACK, N.H.--(BUSINESS WIRE)--Connection (PC Connectio...
SAN JOSE, Calif.--(BUSINESS WIRE)--Bill.com (NYSE:BILL), a leading provider of cloud-based software that simplifies, digitizes and automates financial operations for small and midsize businesses (SMBs), announced today that Aida Álvarez has joined the ...
First quarter 2022 net sales of $1.15 billion, an increase of 4% year-over-year; GAAP net loss attributable to Covetrus of $(2) million Non-GAAP organic net sales growth of 6% year-over-year Non-GAAP adjusted EBITDA increased 11% year-over-year t...
First quarter Net Revenue increased by 19% year over year to $277 million Net Loss improved by $5 million year over year to ($1) million Adjusted EBITDA increased by 10% year over year to $48 million SAN FRANCISCO--(BUSINESS WIRE)--Yelp Inc. (NYSE: ...
Revenue of $143 million, down 18% year over year Transaction Value of $239 million, down 9% year over year Transaction Value from Property & Casualty down 19% year over year to $148 million Transaction Value from Health up 20% year over yea...
Increases 2022 Guidance Executes $25M Accelerated Share Repurchase AUSTIN, Texas--(BUSINESS WIRE)--Green Dot Corporation (NYSE: GDOT) today reported financial results for the quarter ended March 31, 2022. “We delivered another strong quarter with ex...
CHICAGO--(BUSINESS WIRE)--CCC Intelligent Solutions Holdings Inc. (“CCC” or the “Company”) (NYSE: CCCS), a leading SaaS platform for the P&C insurance economy, today announced its financial results for the three months ended March 31, 2022. “CCC d...
Q1 2022 Financial Highlights: Total net revenue was $16.4 million Gross margin was 56% of total revenue Post Quarter End: NaviNet Open Won MedTech Breakthrough “Healthcare Insurance Innovation Award.” This is the second year in a row that ...
SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root causes of cardiometabolic diseases, today announc...
Quarterly revenue 29% above high end of guidance range Reaffirm full-year 2022 guidance AlsoEnergy commercial synergies on track for 2022 bookings Expect minimal impact from AD/CVD inquiry in solar industry First Quarter 2022 Financial and Operati...